Follow
John Frater
John Frater
Verified email at ndm.ox.ac.uk - Homepage
Title
Cited by
Cited by
Year
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
56402021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
29032020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
17662020
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
14042021
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ...
Nature immunology 21 (11), 1336-1345, 2020
12732020
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
P Kiepiela, K Ngumbela, C Thobakgale, D Ramduth, I Honeyborne, ...
Nature medicine 13 (1), 46-53, 2007
12482007
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
9812022
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
RK Gupta, S Abdul-Jawad, LE McCoy, HP Mok, D Peppa, M Salgado, ...
Nature 568 (7751), 244-248, 2019
7372019
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ...
Journal of Crohn's and Colitis 3 (2), 47-91, 2009
7022009
Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum
A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ...
Cell 185 (14), 2422-2433. e13, 2022
6762022
Adaptation of HIV-1 to human leukocyte antigen class I
Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ...
Nature 458 (7238), 641-645, 2009
5642009
Early and nonreversible decrease of CD161++/MAIT cells in HIV infection
C Cosgrove, JE Ussher, A Rauch, K Gärtner, A Kurioka, MH Hühn, ...
Blood, The Journal of the American Society of Hematology 121 (6), 951-961, 2013
3682013
HIV-1 DNA predicts disease progression and post-treatment virological control
JP Williams, J Hurst, W Stöhr, N Robinson, H Brown, M Fisher, S Kinloch, ...
elife 3, e03821, 2014
3322014
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ...
The Lancet Infectious Diseases 20 (12), 1390-1400, 2020
3202020
European Crohn’s and Colitis Organisation (ECCO)
JF Rahier, F Magro, C Abreu, A Armuzzi, S Ben-Horin, Y Chowers, ...
Second European evidence-based consensus on the prevention, diagnosis and …, 2014
3082014
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ...
Cell 184 (23), 5699-5714. e11, 2021
2992021
Selection bias at the heterosexual HIV-1 transmission bottleneck
JM Carlson, M Schaefer, DC Monaco, R Batorsky, DT Claiborne, J Prince, ...
Science 345 (6193), 1254031, 2014
2962014
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
RK Gupta, D Peppa, AL Hill, C Gálvez, M Salgado, M Pace, LE McCoy, ...
The Lancet HIV 7 (5), e340-e347, 2020
2502020
Short-course antiretroviral therapy in primary HIV infection
SPARTAC Trial Investigators
New England Journal of Medicine 368 (3), 207-217, 2013
2452013
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
J Frater, KJ Ewer, A Ogbe, M Pace, S Adele, E Adland, J Alagaratnam, ...
The lancet HIV 8 (8), e474-e485, 2021
2372021
The system can't perform the operation now. Try again later.
Articles 1–20